09 May 2023 | Tuesday | Opinion
By PerkinElmer
To help address these challenges, the cell counting experts at Nexcelom, now part of PerkinElmer, have identified six key points to increase the confidence of cell counting results involving the selection of source materials, methodologies, and instrumentation based on the specific cell requirements and the desired data readout.
Achieving accurate cell counts, viability percentages, and biomarker measurements starts with selecting and evaluating the appropriate cell counting method. This method selection includes deciding the correct cell counting assay, reagents, consumables, and software analysis needed for a particular cell type.
When looking to validate cell counting methods for pre-clinical trials, clinical trials, and process development, the International Organization for Standardization (ISO) Cell Counting Standards Part 1 and 2 provide a framework for evaluating the performance of any cell counting method.
Navigating Cell Counting Method Selection
PerkinElmer and Nexcelom recognize the significance of assisting researchers in applying the ISO Cell Counting Standards to their workflows and have highlighted the factors that can influence the quality of the cell counting results.
Through customer collaborations and internal studies, the Research and Development team developed strategies based on the ISO standards to create a Practical Cell Counting Method Selection Guide to Increase the Quality of Cell Counting Results. These considerations allow researchers to easily adhere to the ISO recommendations and ensure high-quality cell counting measurements.
Six key factors impacting the selection of cell counting methods and the quality of cell counting measurements:
In each of the six areas, there are additional details on how to maintain guidelines, meet standards, and ensure proper method selection of counting cells based on individualized experimentation.
Learn more about understanding ISO cell counting standards in the related Nexcelom webinar Applying ISO Cell Counting Standards for Cell and Gene Therapy Products.
© 2024 Biopharma Boardroom. All Rights Reserved.